Advancing Knowledge,
Improving Patient Outcomes
AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.
CE Courses
Program Overview
This CME post-conference review and analysis will highlight therapeutic advances in the management of patients with gastrointestinal cancer, including data presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022. The expert faculty will analyze the latest therapeutic advances for the treatment and management of gastrointestinal (GI) cancer as presented at ASCO GI 2022. They ...View Course
Welcome to this AcademicCME Nephrology Network Program. These “quick hitting” programs focus on a visual comparison between two important studies in a single issue of importance to those clinicians who care for the kidneys and the patients in which those kidneys live. This Nephrology Network program is accredited for up to 1.5hr CME (physicians) and CE (nurses, NPs, PAs, pharmacists) ...
View Course
View Course
Join Dr. Stephen Krieger (@SKriegerMD), a Professor Neurology at the Corinne Goldsmith Dickinson Center for MS at Mount Sinai, in a unique CE/CME-accredited video. Dr. Krieger sits down for an honest 1:1 conversation with one of his first patients, Kate Milliken, with whom he has had a doctor-patient relationship for 15 years. They discuss how considering the patient’s perspective is ...
View Course
View Course
Program Overview
This CME/CE program is derived from content presented at the Maui Derm for Dermatologists 2022 Annual Meeting. The expert faculty, led by Lawrence Eichenfield, MD, will highlight the use of Janus kinases (JAK) inhibitor therapeutics to improve outcomes in patients with atopic dermatitis. The faculty will begin with an overview of current clinical trial data, including new and ...
View Course
Program Overview
This CME/CE program will outline recent advances in the treatment and management of patients with metastatic breast cancer. The expert faculty, led by Dr. Harold J. Burstein, will first cover ER-positive breast cancer, analyzing data for CDK 4/6 inhibitors, ER targeting agents and antibody drug conjugates. Following, pertinent information regarding triple negative breast cancer will be reviewed, highlighting ...View Course
Program Overview
This CME/CE program will highlight recent advances in disease management of generalized myasthenia gravis (MG) by reducing levels of IgG autoantibodies. The expert faculty, led by Dr. James F. Howard, will first cover the pathophysiology of MG, including therapeutic approaches and general limitations for current immunosuppressant therapies. Following, current clinical trial data of FcRn Inhibitors in myasthenia gravis ...View Course
Upcoming Events
